TY - JOUR
T1 - Enzymatic method for assaying calcium in serum and urine with porcine pancreatic α-amylase
AU - Kayamori, Yuzo
AU - Katayama, Yoshiaki
PY - 1994/1/1
Y1 - 1994/1/1
N2 - We developed a kinetic assay for calcium in serum and urine, based on the activation of porcine pancreatic α-amylase (EC 3.2.1.1) with 2-chloro-4- nitrophenyl-α-maltotrioside as substrate. The kinetic generation of 2- chloro-4-nitrophenol, monitored at 405 nm, was proportional to the concentration of calcium in serum and urine. The assay was developed and evaluated with the Cobas Bio centrifugal analyzer. The average within-run and between-day imprecision (CV) was 0.96/1.26% and 1.07/1.63%, respectively, for serum calcium and 1.50/2.54% and 1.70/2.64%, respectively, for urine calcium. Results of the proposed method (y) correlated well with those determined by atomic absorption spectrophotometry (x): y(serum) = 1.005x + 0.028 mmol/L (S(y/x) = 0.058, r = 0.974, n = 50), and y(urine) = 1.017x - 0.115 mmol/L (S(y/x) = 0.30, r = 0.981, n = 25). We also present data showing that the method is highly sensitive, rapid, relatively free of interference, and amenable to automation.
AB - We developed a kinetic assay for calcium in serum and urine, based on the activation of porcine pancreatic α-amylase (EC 3.2.1.1) with 2-chloro-4- nitrophenyl-α-maltotrioside as substrate. The kinetic generation of 2- chloro-4-nitrophenol, monitored at 405 nm, was proportional to the concentration of calcium in serum and urine. The assay was developed and evaluated with the Cobas Bio centrifugal analyzer. The average within-run and between-day imprecision (CV) was 0.96/1.26% and 1.07/1.63%, respectively, for serum calcium and 1.50/2.54% and 1.70/2.64%, respectively, for urine calcium. Results of the proposed method (y) correlated well with those determined by atomic absorption spectrophotometry (x): y(serum) = 1.005x + 0.028 mmol/L (S(y/x) = 0.058, r = 0.974, n = 50), and y(urine) = 1.017x - 0.115 mmol/L (S(y/x) = 0.30, r = 0.981, n = 25). We also present data showing that the method is highly sensitive, rapid, relatively free of interference, and amenable to automation.
UR - http://www.scopus.com/inward/record.url?scp=0028345898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028345898&partnerID=8YFLogxK
U2 - 10.1093/clinchem/40.5.781
DO - 10.1093/clinchem/40.5.781
M3 - Article
C2 - 8174252
AN - SCOPUS:0028345898
VL - 40
SP - 781
EP - 784
JO - Clinical Chemistry
JF - Clinical Chemistry
SN - 0009-9147
IS - 5
ER -